Menarini Receives European Commission Approval of ELZONRIS (ta...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
FLORENCE, Italy, January 21, 2021 /PRNewswire-AsiaNet/ -- - ELZONRIS is the first approved treatment for patients with BPDCN, and the first approved CD123-targeted therapy, in Europe- Approval is based on the results of the largest prospective clinical trial ever conducted in patients with treatment-...
Authors: LATEST ASIANET NEWS RELEASES